Blood Physiology Hemostasis Dr. Sherwan R Sulaiman MD / MSc / PhD www.doctorsherwan.com - PowerPoint PPT Presentation

1 / 27
About This Presentation
Title:

Blood Physiology Hemostasis Dr. Sherwan R Sulaiman MD / MSc / PhD www.doctorsherwan.com

Description:

Blood Physiology Hemostasis Dr. Sherwan R Sulaiman MD / MSc / PhD www.doctorsherwan.com Events in Hemostasis Hemostasis-prevention of blood loss Mechanisms vascular ... – PowerPoint PPT presentation

Number of Views:180
Avg rating:3.0/5.0
Slides: 28
Provided by: Palm46
Category:

less

Transcript and Presenter's Notes

Title: Blood Physiology Hemostasis Dr. Sherwan R Sulaiman MD / MSc / PhD www.doctorsherwan.com


1
Blood PhysiologyHemostasisDr. Sherwan R
SulaimanMD / MSc / PhDwww.doctorsherwan.com
2
Events in Hemostasis
  • Hemostasis-prevention of blood loss
  • Mechanisms
  • vascular spasm
  • formation of a platelet plug
  • blood coagulation
  • fibrous tissue growth to seal

3
Hemostasis
  • Vascular Constriction-associated w/ trauma
  • neural reflexes
  • SNS induced constriction from pain
  • local myogenic spasm
  • responsible for most of the constriction
  • local humoral factors
  • thromboxane A2 from platelets
  • Spasm ? trauma

4
Platelet Plug
  • Platelets function as whole cells
  • but cannot divide
  • Platelets contain
  • actin myosin
  • enzymes calcium
  • ADP ATP
  • Thromboxane A2
  • serotonin
  • growth factor

5
Platelet Cell Membrane
  • Contains
  • Glycoproteins that avoid the normal
    endothelium but adhere to damaged area
  • Phospholipids containing platelet factor 3
  • a.k.a. thromboplastin-initiates clotting

6
Mechanism of Platelet Activation
  • When platelets contact damaged area they 1)
    swell
  • 2) irregular form w/ irradiating processes
    protruding from surface
  • 3) contractile proteins contract causing
    granule release
  • 4) secrete ADP, Thromboxane A2 serotonin

7
Thromboxane A2
  • 1) Vasoconstrictor
  • 2) Potentiates the release of granule
  • contents
  • (not essential for release to occur)

8
Platelets
  • Important in minute ruptures
  • lack of platelets associated with small
    hemorrhagic areas under skin and throughout
    internal tissues
  • half-life of 8-12 days
  • eliminated primarily by macrophage action
  • (greater than 1/2 of all macrophages in spleen)
  • 150,000-300,000 per ?l

9
Role of Endothelium
  • Prevents platelet aggregation
  • produces PGI2 (prostacyclin)-
  • vasodilator
  • stimulates platelet adenyl cyclase which
    suppresses release of granules
  • limits platelet extension
  • produces factor VIII (clotting)

10
Prostaglandin synthesis
  • Phospholipid ?Arachidonic acid requires Lipase
  • Arachidonic acid?PGG2-PGH2 requires fatty acid
    cyclooxygenase
  • PGG2-PGH2?Thromb. A2 requires Thromb. synthetase
  • PGG2-PGH2?PGI2 requires Prostacyclin synthetase
  • Aspirin and Ibuprofen block Fatty acid
    cyclooxygenase

11
Anticoagulants vs Lysis of clots
  • Anticoagulants
  • prevents clots from forming
  • chelators-tye up calcium (citrate, oxylate)
  • heparin- complexes with Antithrobin III
  • dicumarol-inhibition of Vit. K dependent factors
  • factors II, VII, IX, X (synthesized by
    hepatocytes
  • Aka cumadin, warfarin
  • Lysis of Clots
  • Plasmin (from plasminogen)

12
Activators of Plasminogen
  • Endogenous Activators
  • tissues
  • plasma
  • urine
  • Exogenous Activators
  • streptokinase
  • tPA (tissue plasminogen activator)

13
Aspirin Ibuprofen
  • Block both thromboxane A2 prostacyclin
    production by blocking fatty acid cyclooxygenase
    which converts arachidonic acid to PGG2 PGH2
    (intermediates)
  • Why take aspirin to prevent heart attacks?

14
Reperfusion injury
  • Most of the frank tissue damage associated with
    infarction occurs upon reperfusion
  • associated with the formation of highly reactive
    oxygen species with unpaired electrons. free
    radicals
  • When pressure on tissues relieved again
    perfused with blood, free radicals are generated

15
Collateralization
  • The ability to open up alternate routes of blood
    flow to compensate for a blocked vessel
  • Angiogenesis
  • Vasodilatation
  • Role of the SNS ??
  • May impede
  • May augment

16
Blood Coagulation- Thrombosis
  • Extrinsic mechanism-initiated by chemical factors
    released by damaged tissues
  • Intrinsic mechanism-requires only components in
    blood trauma to blood or exposure to collagen
    (or foreign surface)

17
Clotting factors
  • I- fibrinogen
  • II- Prothrombin
  • III- Thromboplastin
  • IV- Calcium
  • V- Proaccelerin
  • VII- Serum prothombin conversion acclerator
  • VIII- antihemophilic factor (A)

18
Clotting factors (cont.)
  • IX- antihemophilic factor B christmas factor
  • X- Stuart factor
  • XI- antihemophilic factor C
  • XII- Hageman factor
  • XIII- Fibrin-stabilizing factor
  • Prekallikrein- Fletcher factor
  • High molecular weight kininogen
  • Platelets

19
Hepatocytes role in clotting
  • Liver synthesizes 5 clotting factors
  • I (fibrinogen)
  • II (prothrombin)
  • VII (SPCA)
  • IX (AHF B)
  • X (Stuart factor)
  • Coumarin (warfarin or cumadin) depresses liver
    formation of II, VII, IX, X by blocking action of
    vitamin K

20
Hemophilia
  • Sex linked on X chromosome
  • occurs almost exclusively in males
  • 85 of cases- defect in factor VIII
  • 15 of cases- defect in factor IX
  • varying degree of severity from mild ? severe

21
Blood Coagulation
  • The key step is the conversion of fibrinogen to
    fibrin which requires thrombin
  • thrombin
  • fibrinogen---------------gtfibrin

22
Intrinsic pathway
  • Factor XII activated when blood contacts a
    negatively charged surface (collagen, glass)
  • Activated XII Kalikrein Kinnogen will activate
    Factor XI
  • Activated XI Ca will activate both Factors IX
    VIII
  • Activated IX VIII Phospholipid Ca will
    activate Factors X V
  • Activated X V Phospholipid Ca will
    convert Prothrombin to Thrombin

23
Extrinsic Pathway
  • Tissue thromboplastin Factor VII Ca will
    activate Factors X V
  • Activated X V Phospholipid Ca will
    convert Prothrombin to Thrombin

24
Final Common Steps
  • Once Fibrinogen has been converted to Fibrin by
    Thrombin it is changed from the soluble monomer
    to the insoluble polymer by the activated Factor
    XIII
  • Factor XIII is activated by Thrombin and Ca

25
Lysis of Clots
  • Clots may be liquefied by (fibrinolysis) by a
    proteolytic enzyme plasmin
  • It circulates in the blood in an inactive form
    known as plasminogen
  • Activators are found in tissues, plasma, and
    urine
  • It can also be activated by exogenous activators
    such as tPA, or streptokinase

26
Risk factors in Heart Disease
  • Increasing age
  • Male gender
  • Heredity (including race)
  • Tobacco Smoke
  • High blood cholesterol
  • High blood pressure
  • Physical inactivity
  • Obesity/overweight
  • Diabetes Mellitus
  • High blood homocysteine

27
Homocysteine
  • Amino acid in the blood that may irritate blood
    vessels promoting atherosclerosis
  • Can also cause cholesterol to change into
    oxidized LDL
  • Can make blood more likely to clot
  • High levels in blood (gt 12 ?mol/L) can be reduced
    by increasing intake of folic acid, B6 and B12
Write a Comment
User Comments (0)
About PowerShow.com